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Abstract
Background: In the UK public concern about the safety of the combined measles, mumps and rubella [MMR]
vaccine continues to impact on MMR coverage. Whilst the sharp decline in uptake has begun to level out, first and
second dose uptake rates remain short of that required for population immunity. Furthermore, international
research consistently shows that some parents lack confidence in making a decision about MMR vaccination for
their children. Together, this work suggests that effective interventions are required to support parents to make
informed decisions about MMR.
This trial assessed the impact of a parent-centred, multi-component intervention (balanced information, group
discussion, coaching exercise) on informed parental decision-making for MMR.
Methods: This was a two arm, cluster randomised trial. One hundred and forty two UK parents of children eligible
for MMR vaccination were recruited from six primary healthcare centres and six childcare organisations. The
intervention arm received an MMR information leaflet and participated in the intervention (parent meeting). The
control arm received the leaflet only. The primary outcome was decisional conflict. Secondary outcomes were
actual and intended MMR choice, knowledge, attitude, concern and necessity beliefs about MMR and anxiety.
Results: Decisional conflict decreased for both arms to a level where an ‘effective’ MMR decision could be made
one-week (effect estimate = -0.54, p < 0.001) and three-months (effect estimate = -0.60, p < 0.001) post-
intervention. There was no significant difference between arms (effect estimate = 0.07, p = 0.215). Heightened
decisional conflict was evident for parents making the MMR decision for their first child (effect estimate = -0.25,
p = 0.003), who were concerned (effect estimate = 0.07, p < 0.001), had less positive attitudes (effect estimate =
-0.20, p < 0.001) yet stronger intentions (effect estimate = 0.09, p = 0.006). Significantly more parents in the
intervention arm reported vaccinating their child (93% versus 73%, p = 0.04).
Conclusions: Whilst both the leaflet and the parent meeting reduced parents’ decisional conflict, the parent
meeting appeared to enable parents to act upon their decision leading to vaccination uptake.
Background
In the UK public concern about the safety of the com-
bined measles, mumps and rubella [MMR] vaccine as a
consequence of Wakefield et al’s now discredited
research continues to impact on MMR coverage [1]
even though the sharp decline in uptake has begun to
reverse [2]. Current first and second dose MMR uptake
rates in England are 84% and 77% respectively [2], short
of the 95% required for population immunity [3]. As a
consequence, there is a pool of unimmunised children
susceptible to the diseases, reflected in persistent loca-
lised measles outbreaks [4] with an epidemic predicted
in the near future [5]. In some European countries and
in the USA, childhood immunisation is mandatory yet
MMR vaccine refusal has increased, similarly leading to
measles outbreaks [6,7]. Repeated assertions by the
Department of Health for England and Wales and the
U.S Centers for Disease Control and Prevention that the
MMR vaccine is safe have had limited effect on allaying
parents’ concerns in some sections of the community
[8-10]. More than ten years after the publication of
Andrew Wakefield’s now discredited findings [11], there
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improved [12], yet significant numbers continue to lack
confidence in making an MMR decision [9,13-19] and
many criticise what is perceived to be the poor quality
of information provided [9,17].
A recent systematic review [20] identified the decision
support needs of parents making child health decisions
(including immunisation); these related to three themes:
(i) a need for timely, consistent up-to-date evidence
based information tailored to the individual child, deliv-
ered in a variety of formats from trustworthy sources;
(ii) a need to talk with others facing the same decision
to share experiences; and (iii) a need to be in control of
their level of preferred involvement in the decision-mak-
ing process. This suggests that interventions, informed
by parents’ expressed needs of what they would find
helpful to make informed decisions about MMR are
required. However, in spite of a large literature describ-
ing the factors that influence parents’ decisions whether
to vaccinate their child with MMR [21-25], evaluations
of decision support interventions in this context are lim-
ited [26-29].
Informed by a systematic review [20] and an interview
study with parents [9] we developed and evaluated an
evidence-based, parent-centred, multi-component inter-
vention to support informed parental decision-making
for the MMR vaccine. This parent-centred approach is
consistent with Western health policy in which a clini-
cian-patient partnership is emphasised [30-32]. It is also
in line with the fundamental tenets of health promotion
[33] that is based on an ‘engagement’ model of commu-
nication where a key goal is empowerment. The inter-
vention was designed to supplement routine UK
primary care service for childhood vaccination whereby
parents are invited to take their child, free of charge, for
all immunisations on the National Health Service Rou-
tine Childhood Immunisation Schedule [34]. Childhood
vaccination is not mandatory in the UK.
In this paper we report the findings of a cluster rando-
mised controlled trial to evaluate a parent-centred,
multi-component intervention to support informed deci-
sion-making for MMR [35]. The effectiveness data are
presented here. Acceptability of the intervention is
reported elsewhere [36].
Methods
Setting and Participants
The study was approved by the Local Research Ethics
Committee (06/Q1107/25) on 18 May 2006. It was
located in three of 33 wards (electoral district) in Leeds,
England (approx. 770,000 population [37]). Using the
Index of Multiple Deprivation [38] these wards were
selected to represent low, medium and high deprived
geographical areas [mean scores: low = 6.89; medium =
29.22; high = 55.07]. Primary healthcare centres employ-
ing at least two medical practitioners were purposively
selected based on their low income scheme index [LISI,
39] scores. For example, in the high deprived ward, we
approached centres with the most deprived practice
population first (i.e. highest LISI score). Childcare orga-
nisations in the same wards were approached on the
basis of size, the largest first. Eleven (of 15) healthcare
centres and six (of eight) childcare organisations were
invited to participate. Six primary care centres and six
childcare organisations agreed.
Within these providers the target sample was parents
who were English literate with a child eligible for the
first or second dose MMR vaccination. At the time of
the study, in the UK, the first dose was given at 13
months and the second dose between four and five and
half years of age [34]. The target age range was, there-
fore, six months to five years. Letters were sent to eligi-
ble parents on providers’ registers. Parents replied to the
research team and were telephoned for screening and
recruitment. Recruitment occurred May to July 2006.
Design and Intervention
The design was a cluster randomised controlled trial
design with two arms: intervention and control. This
design was chosen to reduce the potential risk of con-
tamination between arms. The six healthcare centres
and six childcare organisations were matched in pairs
based on their ward (three pairs of healthcare centres,
three pairs of childcare organisations). One of each pair
was randomly allocated to the intervention, the other to
the control arm. A researcher not involved in the study
and blind to the identity of clusters performed the ran-
domisation using a sealed envelope procedure. The
study researcher (RP) was blind to arm assignment
when screening and recruiting parents, and sending out
the baseline questionnaire. Statisticians (WH, RW) saw
blinded data. Parents were blind to arm assignment at
recruitment and in completing the baseline
questionnaire.
Parents allocated to the intervention arm were invited
to attend one two-hour parent meeting, co-facilitated by
a researcher (CJ, FMC, RP) and a parent. Three parent
facilitators (all women) were recruited from local com-
munities. They received one half-day training. In
advance of the meeting parents were sent an informa-
tion leaflet (’MMR your questions answered’,[ 4 0 ] ) .T h e
content and delivery of the parent meeting (see Table 1)
was informed by interviews with 69 parents [9] and a
systematic review of parents’ decision support needs
[20]. This was refined in two focus groups with local
parents. The meeting included three components: provi-
sion of balanced information, a group discussion and a
coaching exercise [41].
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leaflet.
Measures
Parent characteristics (e.g. age, ethnicity) were collected
by telephone at recruitment. Primary and secondary
outcomes were collected by postal questionnaire prior
to randomisation (T1), one week post-intervention (T2)
and three months post-intervention (T3). The question-
naire was developed in collaboration with an expert in
the field of health decision-making (HB) and piloted
with five parents, though no changes were made.
Impact of the parent meeting and MMR leaflet
The primary outcome measure was decisional conflict as
measured by the Decisional Conflict Scale [42]. This
generic measure is a 16-item scale to assess people’s
perceptions about the quality of their decision-making
process; it has five sub-sections for being informed,
clear about their values, degree of support, uncertainty
with the choice, effectiveness of their decision. It has
demonstrated test-retest reliability, construct and pre-
dictive validity in the patient health decision-making
context [42]. Scores range from 1 (no decisional con-
flict) to 5 (extremely high decisional conflict). Scores
lower than two are associated with ‘implementing
decisions’, higher scores are interpreted as ‘decision
delay or feeling unsure about implementation’.H i g h
Cronbach alpha coefficients of 0.95 (T1), 0.92 (T2) and
0.94 (T3) were achieved.
Secondary outcomes were self-reported measures of
the decision (actual and intended actions), attitude
towards MMR and beliefs about the MMR options,
knowledge and anxiety.
The MMR decision w a sm e a s u r e da tt h r e em o n t h s
post-intervention using a self-report item ‘Since this
study started, have you taken your child to have the
combined MMR vaccine?’ In addition, a measure of
intended choice was developed using three items mea-
s u r e do na7 - p o i n ts c a l ee . g .‘I intend to give my child
the combined MMR vaccine at the recommended ages’
(definitely do not-definitely do) [43]. These three items
were measured at all three time-points. Responses were
averaged over the three items. Cronbach alpha coeffi-
cients of 0.84 (T1), 0.79 (T2) and 0.90 (T3) were
obtained.
Knowledge about MMR and the measles disease was
measured using multiple choice items developed for the
purposes of this study using Department of Health for
England and Wales literature [44]. The measure was not
validated. The number of questions answered correctly
Table 1 Overview of parent meeting
Time Facilitator Content Aims
15
minutes
Parent facilitator
and Researcher
WELCOME
Introductions
Outline aims of meeting
Go through programme
Agree ground rules for meeting
Of meeting
To provide parents with the opportunity to discuss MMR
with other parents who are making an MMR decision
To provide information about MMR from a variety of
perspectives
To introduce and practice one approach to supporting
parents to ask questions about MMR of their healthcare
practitioner
30
minutes
Parent facilitator GROUP DISCUSSION
Aim of session
Reminder of ground rules
Introductory question - would anyone like to tell us what
you hoped to get out of this parent meeting today?
Discussion
Of session
To provide parents with the opportunity to discuss any
issues about MMR with other parents who are also making
an MMR decision
30
minutes
Immunisation
Nurse Specialist
QUESTION AND ANSWER SESSION
Aim of session
Parents ask questions of the immunisation nurse specialist
Parents are alerted to resources that they can take away
Of session
To provide parents with the opportunity to ask questions of
the immunisation nurse specialist
35
minutes
Researcher COACHING EXERCISE
Aim of session
Brief input on the importance of raising questions about
MMR with a healthcare practitioner
Introduce and discuss the question prompt sheet
Role play exercise using the question prompt sheet
Brief discussion on usefulness of the question prompt
sheet and role play
Of session
To introduce and practice one approach to supporting
parents to ask questions about MMR in the primary care
consultation
10
minutes
Parent facilitator
and Researcher
CLOSE OF MEETING
Thank parents and provide overview of next stage of
research study
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Page 3 of 11were summed to produce a total knowledge score (max-
imum 11).
Attitude towards MMR was measured on a 7-point
scale [43]. Parents responded to the statement ‘For me
to give my child the combined MMR vaccine at the
recommended ages would be’ on three semantic differ-
ential evaluative endpoints (1 to 7); e.g. extremely bad/
extremely good. Responses were averaged over the three
items. Cronbach alpha coefficients were 0.78 (T1), 0.73
(T2) and 0.80 (T3). These intended choice and attitude
items have demonstrated validity and reliability and
were informed by guidelines on measuring health cogni-
tions [44].
Parents’ beliefs about the MMR options were assessed
using a modified version of the Beliefs about Flu Vacci-
nation Questionnaire [45]. The measure was not vali-
dated for use in this context. Four items assessed
parents’ beliefs about the necessity of MMR e.g. ‘With-
out the combined MMR vaccine, my child could get
very ill from measles, mumps or rubella’ and four items
assessed parents’ concerns about MMR e.g. ‘Giving my
child the combined MMR vaccine worries me’. All items
were scored on a 5-point scale (strongly disagree-
strongly agree). Items for each sub-scale were summed.
Total scores for the two scales range from 4 to 20 with
higher scores representing stronger beliefs in the neces-
sity for, and concerns about, MMR. Cronbach alpha
coefficients for the necessity sub-scale were 0.70 (T1),
0.63 (T2) and 0.70 (T3). Reliability was not improved by
eliminating any items. Cronbach alpha coefficients for
the concerns sub-scale were 0.77 (T1), 0.75 (T2) and
0.78 (T3).
Anxiety was measured to ensure that the parent meet-
ing and MMR leaflet did not evoke anxiety in parents.
We used the short form STAI [46]. Six items were used
e.g. ‘I feel calm’, ‘Ia mt e n s e ’ and were scored on a 4-
point scale (not at all-very much). The positive items (e.
g. calm) were reverse scored and all six items were
summed. The total score was multiplied by 20/6. A nor-
mal score is 34 to 36. High Cronbach alpha coefficients
of 0.81 (T1), 0.86 (T2) and 0.84 (T3) were obtained.
Sample size
To achieve 80% power to detect a standardised effect
size of 0.67 on the primary outcome of decisional con-
flict [42,47], using a two-sided t-test with significance
level of 0.05 and an estimated ICC of 0.05 (giving a
design effect of 1.5 based on an average of 11 parents
per cluster) required a sample size of 108 parents (54 in
each group). Predicting 25% attrition 73 parents were
required in each group. Parent numbers were not
balanced across the clusters. Based on our previous
research [9] we estimated recruiting 12 parents per
week over three months.
Analysis
An intention to treat analysis was conducted. This trial
design was clustered within centres (healthcare centres,
childcare organisations) and had repeated measures. The
number of clusters and parents within each cluster were
small in respect to multilevel modelling. To explore the
potential effectiveness of the intervention on the pri-
mary outcome (decisional conflict) longitudinal analysis
was used. This accounted for the multilevel structure of
the data, with outcome measures collected at different
time points within parent data. We were interested in
exploring how decisional conflict changed over time
with respect to covariates of interest, namely arm, focal
MMR decision, parent characteristics (age, ethnicity,
marital status, education, relationship to child, if have
older child) and intended choice, knowledge, attitude,
beliefs and anxiety at recruitment. A normal model was
used, using MLwiN 2.10 beta 5 to perform these
analyses.
Due to missing values, owing to non-completion of
some questionnaire items, complete case analysis cor-
r e s p o n d e dt oo n l y6 5 %o ft h ed a t a .O ft h e s e9 2p a r -
ents, 44 (48%) were in the intervention arm and 48
(52%) were in the control arm. Missing values
appeared to be at random. Multiple imputation was
undertaken in Stata 10.0 to account for this. Five
imputed datasets were generated using the results
from linear regression analyses. Prior to undertaking
multiple imputations seven parents were excluded (n =
3 intervention; n = 4 control) as they had not com-
pleted any study questionnaires, providing only parent
characteristics data at recruitment. The best fit model
for the complete case data was fitted to each imputed
dataset and compared with the best fit model for those
data. All imputed datasets agreed on the importance of
the significant variables in the complete case model
and results were found to be similar, thus indicating
that minimal bias was introduced due to missing
values. Aggregated results from the five imputed data-
sets using 135 participants (142 minus 7) are pre-
sented. Confidence intervals were calculated using the
widest values to allow for errors generated through the
imputation. Two sided significance tests and an alpha
level of 0.05 were used throughout.
Repeated measures ANOVAs were computed for the
secondary outcome measures using multilevel modelling
using the aggregated results from the five imputed data-
sets. Chi squared analysis explored MMR uptake by
arm.
Results
Intervention delivery
The parent meeting was delivered eight times during
July and August 2006 in non-healthcare venues (e.g.
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Page 4 of 11community centres) close to participating healthcare
centres and childcare organisations. Four daytime and
four evening meetings were organised. Crèche facilities
were provided at three daytime meetings. Forty one par-
ents attended a parent meeting, 23 did not. Parents
attending the meeting did not differ from those not
attending the meeting in their characteristics or in their
decisional conflict levels at baseline. The mean number
of parents attending was 6 (range: 2 to 10). One meeting
had less than four parents attending.
Clusters and participants
Participant flow through the study is presented in
Figure 1. The two arms were equivalent on all but one
cluster characteristic. Mean list size for the childcare
organisations was larger for the control arm (Table 2).
Of 1447 eligible parents invited, 150 (10%) consented
to participate. Eight parents did not meet the inclusion
criteria (did not have an ‘actual’ MMR decision to make
at that time). Recruitment of 142 parents fell short of
the 146 target allowing for 25% attrition, but the
 
 
 
 
 
 
 
 
Assessed for eligibility 
(11 Healthcare centres HC,   
6 Childcare organisations 
CO) 
Excluded: 
Refused to participate (5 HC) 
Analysed 
(3 HC, 3 CO) 
(68 parents of 71) 
Excluded from analysis 
(3 parents only provided parent 
characteristics data) 
Lost to T2 follow-up  
(0 HC, 0 CO) 
(6 parents of 71 did not return T2 
questionnaire) 
 
Lost to T3 follow-up  
(0 HC, 0 CO) 
(13 parents of 71 did not return T3 
questionnaire) 
Allocated to intervention 
(3 HC, 3CO) 
(71 parents) 
Received allocated intervention 
(3 HC, 3 CO) 
(48 parents) 
Did not receive allocated intervention 
(0 HC, 0 CO) 
(23 parents did not attend meeting) 
Lost to T2 follow-up  
(0 HC, 0 CO) 
(7 parents of 71 did not return T2 
questionnaire) 
 
Lost to T3 follow-up  
(0 HC, 0 CO) 
(7 parents of 71 did not return T3 
questionnaire) 
Allocated to control 
(3 HC, 3 CO) 
(71 parents) 
Received control intervention 
(3 HC, 3 CO) 
(71 parents) 
Did not receive control intervention 
(0 HC, 0 CO) 
(0 parents) 
Analysed 
(3 HC, 3 CO) 
(67 parents of 71) 
Excluded from analysis 
(4 parents only provided parent 
characteristics data) 
 
Allocation 
Analysis 
Follow-Up 
Enrollment 
Randomised  
(6 HC, 6 CO) 
Figure 1 Participant flow.
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because of a less than anticipated drop out.
The two arms were equivalent on all parent character-
istics (Table 2). There was a difference in the age of the
first (youngest) eligible child and therefore in the MMR
decision parents were making. One third of parents in
the intervention arm were making a first dose decision
compared with almost two thirds in the control arm.
Dose decision was therefore modelled in the analysis.
Impact of the parent meeting and MMR leaflet
Was the parent meeting associated with a reduction in
decisional conflict?
Mean decisional conflict by arm over time is pre-
sented in Figure 2. At recruitment parents in both
arms reported levels of decisional conflict above two
indicating that they had sufficient conflict about the
choice to interfere with making the MMR decision
effectively [42].
At one week post-intervention mean decisional con-
flict had decreased for both arms to below two; and
remained below two at three months post-intervention.
Time was significantly associated with decisional con-
flict. There was no significant association between arm
and decisional conflict at any time point (see Table 3).
In short, post-intervention, parents could implement an
effective decision irrespective of arm allocation. The
greatest reduction in decisional conflict occurred at one-
week post-intervention. Focal MMR decision (first or
second dose) was not significantly associated with
Table 2 Baseline characteristics of clusters and parents by arm
Characteristics Intervention arm Control arm
Primary healthcare centres, n 3 3
Childcare organisations, n 3 3
Mean healthcare centre parent list size 216 210
Mean childcare organisation parent list size 19 30
Mean Low Income Scheme Index score
a 10 11
Parents, n 71 71
Mean age ± SD, yrs 34.07 ± 5.43 34.06 ± 5.52
Ethnicity, n (%)
White British 68 (95.8%) 68 (95.8%)
Other 3 ( 4.2%) 3 ( 4.2%)
Marital status, n (%)
Single or living with partner 27 (38.0%) 13 (18.3%)
Married or re-married 40 (56.4%) 57 (80.2%)
Separated/Divorced/Widowed 4 .(5.6%) 1 (1.5%)
Relationship to eligible child, n (%)
Mother 67 (94.4%) 67 (94.4%)
Father 4 (5.6%) 4 (5.6%)
Education
Left school at 16 years 24 (33.8%) 25 (35.2%)
Left school at 18 years 10 (14.1%) 10 (14.1%)
Achieved Degree or higher 37 (52.1%) 36 (50.7%)
Have older child
Yes 36 (50.7%) 36 (50.7%)
No 35 (49.3%) 35 (49.3%)
First (youngest) child eligible, n (%) First dose MMR decision 23 (32.4%) 44 (62.0%)
Second dose MMR decision 48 (67.6%) 27 (38.0%)
Mean age ± SD of first (youngest) child eligible, months 25.73 ± 14.66 19.77 ± 11.69
Second youngest child eligible, n (%)
First dose MMR decision 1 ( 4%) 0 (0.00%)
Second dose MMR decision 24 (96%) 22 (100.0%)
Mean age ± SD of second youngest child eligible, months 50.56 ± 17.13 49.32 ± 21.41
Note. N = 12 clusters, N = 142 parents.
aLow Income Scheme Index score is based on the percentage of prescribed items exempt from a prescription charge due
to low income of the patient.
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Page 6 of 11decisional conflict i.e. perceived decisional conflict about
this choice reduced over time for parents making first
or second dose decisions.
Was the parent meeting associated with MMR decision?
Sixty six parents provided self-report data about their
MMR choice. Of these 66, 29 (44%) were in the
intervention arm and 37 (56%) were in the control arm.
The remaining parents did not have children who were
invited for vaccination within the study time period.
Ninety three percent of parents in the intervention arm
reported taking their child for the vaccination compared
to 73% in the control arm. This difference was statisti-
cally significant (c
2 (1, N = 66) = 4.43, 95% confidence
interval 3.1% to 37.2%, p = 0.04).
Was the parent meeting associated with changes in
parents’ intended choice, knowledge, attitudes, beliefs or
anxiety?
Time by group mean scores, 95% confidence intervals
and significance levels for secondary outcomes are pre-
sented in Table 4. Small changes in the predicted direc-
tion were evident for the intervention arm for
knowledge, intended choice, attitudes, and beliefs. How-
ever repeated measures ANOVAs revealed no significant
time by arm effects. Mean anxiety remained below or
within the normal range suggesting that neither the par-
ent meeting nor the MMR leaflet evoked anxiety in
parents.
Which parent characteristics and cognitions were
associated with changes in decisional conflict?
Baseline parent characteristics and outcome measures
(irrespective of arm allocation) associated with changes
Table 3 Coefficients for the longitudinal multilevel model
of decisional conflict on potential covariates
Model variables Effect
Estimate
95% CI p-
value
Time-1 week post-intervention -0.54 -0.67 to
-0.41
<0.001
Time-3 months post-
intervention
-0.60 -0.73 to
-0.47
<0.001
Arm-intervention 0.07 -0.11 to
0.25
0.215
MMR decision-2
nd dose -0.05 -0.24 to
0.14
0.310
Older child -0.25 -0.42 to
-0.07
0.003
Intended choice 0.09 0.02 to 0.17 0.006
Attitude -0.20 -0.30 to
-0.10
<0.001
Concern beliefs 0.07 0.04 to 0.10 <0.001
Note. N = 135. Results are presented per one point increase of decisional
conflict.
1.6
1.8
2
2.2
2.4
2.6
2.8
Recruitment One week Three months
Time
M
e
a
n
 
D
e
c
i
s
i
o
n
a
l
 
C
o
n
f
l
i
c
t
Intervention
Control
Figure 2 Mean decisional conflict by arm over time. Intervention/Control Note. Scores lower than two are associated with ‘implementing
decisions’, higher scores are interpreted with decision delay or feeling unsure about implementation.
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Page 7 of 11in decisional conflict were: whether the parent had an
older child; intended choice, attitude and concern beliefs
(see Table 3).
If a parent had previously made an MMR decision for
an older child, decisional conflict decreased over time
by 0.25 compared to a parent who had not previously
made an MMR decision.
Parents’ concerns about the potiential adverse conse-
quences of MMR at recruitment were significantly asso-
ciated with changes in decisional conflict over time. The
more concerned parents were, decisional conflict
increased by 0.07.
For each additional point increase in attitude i.e. the
more positive parents were about MMR, decisional con-
flict decreased by 0.20. For each additional point
increase in intended choice, i.e. the stronger parents’
intentions were to vaccinate, decisional conflict
increased by 0.09.
Discussion
In response to a continuing lack of confidence amongst
many UK parents facing a decision about MMR [13-19]
and informed by our earlier work [9,20] we developed
and evaluated a parent-centred, multi-component inter-
vention, delivered in community-based (non-healthcare)
v e n u e s .W eb e l i e v et h i st ob et h ef i r s ts t u d yt oe v a l u a t e
a multi-component intervention to support informed
decision making for MMR. Some study limitations
should be acknowledged. Parent numbers were not
balanced across the clusterst h u sr e d u c i n gs t a t i s t i c a l
power. However it seems unlikely that this would have
changed the non-significant time by arm effect for deci-
sional conflict. Only a small number of parents provided
self-report data about their choice thus the study may
have been under powered on this secondary outcome.
T h es t u d yw a sb a s e di no n ec i t ya n do n l y1 0 %o fp a r -
ents invited to take part did so. Due to the Data Protec-
tion Act [48] we cannot determine if they differ to non-
responders. However the immunisation policy in Leeds
mirrors UK policy and the sample was consistent with
other MMR research that identifies parents who find it
difficult to make this decision [9,13,22]. Finally, whilst
complete case analysis was undertaken on just 65% of
the data we believe that minimal bias was introduced.
The intervention was feasible to deliver in non-health-
care, community venues and it was acceptable to par-
ents, with the majority expressing positive views [36].
Parents were equally positive about the MMR leaflet
[36]. Our measure of decisional conflict showed a statis-
tically significant decrease over time for both the inter-
vention and control arms to a level where an informed
decision for MMR could be made.
The positive effect of the MMR leaflet on decisional
conflict observed in the control arm was unexpected.
Table 4 Descriptive data for secondary outcomes
Intervention Control
Outcome Time point Mean 95% CI Mean 95% CI p-value
a
Knowledge
b T1 6.38 6.00- 6.77 5.97 5.53- 6.41 0.253
T2 8.22 7.84- 8.60 7.83 7.52- 8.15
T3 7.30 6.93- 7.66 7.08 6.80- 7.36
Intended choice
c T1 5.93 5.54- 6.32 5.10 4.60- 5.60 0.605
T2 6.03 5.67- 6.39 5.44 4.96- 5.92
T3 6.34 6.00- 6.68 5.58 5.06- 6.09
Attitude
d T1 4.98 4.66- 5.30 4.52 4.17- 4.88 0.786
T2 5.19 4.89- 5.48 4.77 4.44- 5.10
T3 5.26 4.96- 5.55 4.68 4.33- 5.04
Necessity beliefs
e T1 16.88 16.22-17.53 16.73 15.99-17.47 0.578
T2 17.63 16.97-18.28 17.18 16.49-17.87
T3 17.43 16.87-18.00 17.21 16.46-17.96
Concern beliefs
e T1 9.83 8.92-10.73 11.00 10.04-11.96 0.939
T2 8.92 8.15- 9.70 10.15 9.07-11.22
T3 8.66 7.81- 9.50 10.06 9.04-11.09
Anxiety
f T1 32.50 29.63-35.37 34.20 31.52-36.89 0.219
T2 30.89 28.00-33.77 33.78 30.43-37.13
T3 31.46 28.49-34.43 33.39 30.09-36.68
Note. N = 135.
aSignificance value for time by arm interaction. Values range from
b0 (no knowledge) to 11 (good knowledge);
c1(definitely do not intend) to 7
(definitely do intend);
d1 (extremely negative attitude) to 7 (extremely positive attitude);
e4 (not at all necessary/concerned) to 20 (very necessary/concerned);
f20
(low anxiety) to 80 (high anxiety).
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Page 8 of 11The inclusion of the leaflet was to reduce possible bias
from a ‘Hawthorne’ effect [49]. Further, we considered
the provision of a leaflet reflected usual vaccination
practice. However, parents reported during meetings
and in questionnaires that, contrary to stated local vac-
cination policy, leaflets were not routinely provided. For
some parents this may have been because their child
was not invited for MMR vaccination at the time of the
study. Nevertheless, parents reported that this leaflet
was more helpful in addressing their concerns about
MMR compared to the usual Department of Health
information at that time. Consequently instead of com-
paring our intervention with a control (usual care) we
were comparing two different decision support interven-
tions, a decision support leaflet versus participation in a
parent meeting and a decision support leaflet. We were,
therefore, unable to identify the independent effects on
perceptions about the decision process of the parent
meeting from usual care as originally intended.
This study did find that parents in the intervention arm
were significantly more likely to report taking their child
for the MMR vaccination than parents in the control
arm. This suggests that providing information in a well-
designed leaflet may be insufficient to lead to subsequent
changes in the final choice (i.e. taking the child for
immunisation). Enabling parents to act on their informed
d e c i s i o n sm a yr e q u i r eam o r ep r o - a c t i v ea p p r o a c ht h a n
increasing knowledge and enabling clarification of their
values [47]. In this study, it seems likely that the parent
meetings provided sufficient decision support to enable
parents to act on their decision, possibly illustrating a
greater values-choice outcome. Parents making ‘proxy’
decisions about MMR on behalf of a child may require
additional decision support where vaccination/non-vacci-
nation consequences of regret and blame may be com-
mon and where media-induced controversy has adversely
affected public trust in government and medical authori-
ties [8,16]. In this vaccination context, the more proactive
of the two decision support interventions was associated
with more children receiving the MMR vaccination. We
suggest that the concerns parents felt about this choice
were met more fully by both interventions in this study
than those parents who receive standard invitation letters
for, and advice about, MMR in the UK [29].
Interestingly, for both groups the observed improve-
ments in informed decision-making occurred for parents
making first and second dose decisions. Previous research
[ 9 ]w o u l ds u g g e s tt h a tt h ef i r s td o s ed e c i s i o n( f o raf i r s t
child) is the most anxiety-provoking and that parents
may, therefore, experience greater uncertainty. Our study
suggests that parents may benefit from concerted deci-
sion support for both doses. We also found that parents
who had not previously made an MMR decision for an
older child, those who were less positive in their attitude
and more concerned about MMR had higher decisional
conflict. These parents could usefully be targeted for
decision support. Our finding that parents with strong
intentions to vaccinate had higher decisional conflict sug-
gests targeting parents who are approaching vaccination
in the near future rather than those for whom vaccina-
tion and its potential consequences are more remote.
The majority of decision support research focuses on
preference sensitive decisions [50] for which the ‘best’
decision is considered to be unclear and dependent on
personal values. Immunisation is considered to be an
‘effective’ health decision [51] for which the weight of
the scientific evidence would typically lead a health pro-
fessional to recommend a particular course of action.
This perhaps explains why governments and health pro-
fessionals have historically adopted the ‘knowledge defi-
cit model’ approach [52] of simply providing
information and reassurance to parents. Irrespective of
how childhood immunisation ‘delivery systems’ are orga-
nised [34,53], there is evidence from international litera-
ture [20] that parents’ decision support needs are
generally the same. Moreover, the below target MMR
uptake rates in many countries suggests that reliance on
a passive information-giving approach has limited effect.
Comprehensive decision support, as provided in our
parent meeting offers a potential solution.
Conclusions
Whilst both the leaflet and the parent meeting reduced
parents’ decisional conflict, the parent meeting appeared
to enable parents to act upon their decision leading to
vaccination uptake. We are now testing the effectiveness
of a web based MMR decision aid [27,54] for parents
that could be made easily accessible, for example in
public places where parents frequent such as schools,
libraries, community centres as well as in the waiting
rooms of healthcare centres.
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